Santa Fe – Today, a memorial to add opioid use disorder as a qualifying condition to the state Medical Cannabis Program passed the House Floor. HM 67, introduced by Joanne J. Ferrary (D-Las Cruces) and Deborah A. Armstrong (D-Albuquerque), would provide an alternative to opioids in acute and chronic pain management and in preventing and treating opioid use disorders.
“This is a common sense step to addressing the opioid epidemic. Opioid use disorder often goes untreated because medication assisted treatment is not accessible to many residents of New Mexico, especially those living in rural areas of the state,” said Rep. Joanne Ferrary. “This proposal would provide patients with a new option to discuss with their medical providers.”
“We have seen states all over the country benefit from the use of medical cannabis in treating opioid dependency. If patients have access to cannabis use – which is less addictive and harmful than opioids – to increase the effectiveness of pain treatment, then our communities as a whole will be better off for it,” said Rep Deborah Armstrong.
Every day, more than ninety Americans die from opioid overdose and many of these opioids are prescribed to patients for the treatment of pain. There is a growing body of research showing that medical cannabis may be a safe alternative allowing the replacement or reduction of opioid-based treatments, reducing the risk and number of opioid-related deaths. The memorial is also sponsored by Reps. Bill McCamley (D-Mesilla Park), Christine Trujillo (D-Albuquerque), and Rodolpho "Rudy" S. Martinez (D-Bayard).